Maxillofacial abnormalities are the most deleterious to a person's self-esteem and quality of life. Restoration of speech, deglutition, and masticatory functions as well as achieving a normal orofacial appearance are the main objectives of rehabilitation of maxillofacial defects. Any prosthesis can be held in place by anatomical, mechanical, chemical, or surgical anchorage, depending on the clinical scenario. Various methods of retention have evolved over a period of time. Osseointegrated implants have been employed to enhance the retention of facial prosthesis, in the last 20 years. The prosthodontist should be familiar with all the available options, to opt for the appropriate retentive method, while planning for the prosthetic rehabilitation for the patient. In all cases of maxillofacial deformities, optimal outcomes could be a challenging task to accomplish, but careful evaluation, clinical decision-making, and planning can result in prosthesis of acceptable quality that might enhance the patient's quality of life.
Coronavirus Disease 2019 (COVID-19), during the second wave in early 2021 has created devastating chaos. Adding more burden to such a challenging situation, mucormycosis an angioinvasive, fulminant fungal infection has seen a sudden surge in patients with COVID -19. Mucormycosis commonly affects immunocompromised patients. Early diagnosis, elimination of the predisposing factor, and surgical debridement, along with antifungal therapy, are the key factors responsible for successful treatment and patient survival. Mucormycosis is presented by various clinical forms. The present paper reviews about the clinical presentation, diagnosis and various treatment modalities for managing mucormycosis-"the deadly fungal disease".
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.